文献速递妇科

衰弱对卵巢癌术后再入院及医疗费用的影响

Effect of frailty on postoperative readmissions and cost of care for ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2020-08-28

本研究利用全国再入院数据库,分析2010至2014年76,441例卵巢癌开腹手术患者,衰弱发生率为6.1%。衰弱与指数住院期间重症监护、非 routine 出院及住院死亡率升高相关,并与90天再入院及再入院期间死亡率升高相关,但再入院费用无显著差异。

要点

  • 衰弱与卵巢癌开腹术后指数住院期间重症监护风险升高相关(aRR=1.76)。
  • 衰弱患者90天再入院风险升高(aRR=1.11),再入院期间死亡风险亦升高(aRR=1.31)。
  • 衰弱与非衰弱患者再入院费用无显著差异。

核心结论

  • 衰弱影响卵巢癌患者术后结局,与90天再入院率升高及再入院患者死亡率升高相关。
  • 妇科肿瘤医生应筛查衰弱,并在术前咨询时考虑衰弱卵巢癌患者的结局。

研究设计与样本

  • 利用全国再入院数据库(Nationwide Readmissions Database)识别2010至2014年因卵巢癌行开腹手术的患者。
  • 采用约翰霍普金斯调整临床组衰弱诊断指标(Johns Hopkins Adjusted Clinical Groups Frailty Diagnoses Indicators)分类衰弱。
  • 主要结局分为指数住院期间(重症监护级别、死亡率、非常规出院)、30天(再入院和死亡率)及90天(再入院和死亡率)。
  • 拟合多变量回归模型,调整患者、医院和临床因素。

主要发现

  • 2010至2014年共识别76,441例住院开腹手术,衰弱率为6.1%。
  • 衰弱与指数住院期间重症监护级别风险升高相关(aRR=1.76,95% CI:1.68,1.85)。
  • 衰弱与指数住院期间非常规出院风险升高相关(aRR=1.39,95% CI:1.33,1.45)。
  • 衰弱与指数住院期间住院死亡率升高相关(aRR=1.91,95% CI:1.63,2.23)。
  • 衰弱患者90天内再入院风险更高(aRR=1.11,95% CI:1.04-1.18),90天再入院期间死亡风险更高(aRR=1.31,95% CI 1.01-1.69),且指数住院时间更长、费用更高。

临床怎么用

  • 妇科肿瘤医生应筛查衰弱,并在术前咨询时考虑衰弱卵巢癌患者的结局。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Frailty, defined as loss of reserve and vulnerability to changes in health, affects many ovarian cancer patients who are planned to undergo surgery. The effect of frailty on postoperative readmissions in ovarian cancer patients remains poorly defined. We investigated the effect of frailty on unplanned readmission, morbidity, and mortality among patients undergoing surgery for ovarian cancer. STUDY DESIGN: Patients who underwent laparotomy for ovarian cancer between 2010 and 2014 were identified using the Nationwide Readmissions Database. Frailty was classified using the Johns Hopkins Adjusted Clinical Groups Frailty Diagnoses Indicators. Primary outcomes were divided into index admission (intensive level of care, mortality, non-routine discharge,) 30-days (readmission and mortality), and 90-days (readmission and mortality). Multivariable regression models were fit, adjusting for patient, hospital, and clinical factors. RESULTS: From 2010 to 2014, there were 76,441 inpatient laparotomies identified with a 6.1% frailty rate. Frailty was associated with an increased risk of intensive level of care (aRR = 1.76, 95% CI: 1.68, 1.85), non-routine discharge (aRR = 1.39, 95% CI: 1.33, 1.45), and inpatient mortality (aRR = 1.91, 95% CI: 1.63, 2.23) during the index admission. Frail patients were more likely to be readmitted within 90 days (aRR = 1.11, 95% CI: 1.04-1.18), sustain mortality during 90-day readmission (aRR = 1.31, 95% CI 1.01-1.69), and have longer and costlier index hospital stays. Hospital readmission costs did not differ significantly between frail and non-frail patients. CONCLUSIONS: Frailty affects postoperative outcomes in ovarian cancer patients and is associated with an increased rate of 90-day readmission and mortality among those who are readmitted. Gynecologic oncologists should screen for frailty and consider outcomes in frail ovarian cancer patients when counseling for surgery.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Sia TY, Wen T, Cham S, et al. Effect of frailty on postoperative readmissions and cost of care for ovarian cancer. Gynecol Oncol. 2020. PMID: 32868087. doi:10.1016/j.ygyno.2020.08.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。